Viewing Study NCT04960202


Ignite Creation Date: 2025-12-25 @ 3:53 AM
Ignite Modification Date: 2026-05-17 @ 1:41 PM
Study NCT ID: NCT04960202
Status: COMPLETED
Last Update Posted: 2025-07-10
First Post: 2021-07-10
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: EPIC-HR: Study of Oral PF-07321332/Ritonavir Compared With Placebo in Nonhospitalized High Risk Adults With COVID-19
Sponsor: Pfizer
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: C4671005
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators